4//SEC Filing
Doherty Michael J 4
Accession 0001209191-18-041544
CIK 0001488613other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:07 PM ET
Size
5.6 KB
Accession
0001209191-18-041544
Insider Transaction Report
Form 4
Doherty Michael J
Head of Product Development
Transactions
- Sale
Common Stock
2018-07-02$136.66/sh−2,675$365,566→ 81,287 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on July 1, 2018. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F2]The reporting person previously reported restricted stock units granted to the reporting person on (1) April 1, 2017 in Table I of the Form 3 filed on July 5, 2017 and (2) April 1, 2018 in Table I of the Form 4 filed on April 3, 2018. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting events related to this securities sale.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeother
Related Parties
1- filerCIK 0001710939
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:07 PM ET
- Size
- 5.6 KB